Upstream Bio Inc (NASDAQ:UPB)’s traded shares stood at 0.74 million during the last session. At the close of trading, the stock’s price was $7.62, to imply a decrease of -5.34% or -$0.43 in intraday trading. The UPB share’s 52-week high remains $29.46, putting it -286.61% down since that peak but still an impressive 12.73% since price per share fell to its 52-week low of $6.65. The company has a valuation of $408.74M, with an average of 0.24 million shares in intraday trading volume over the past 10 days and average of 238.67K shares over the past 3 months.
Upstream Bio Inc (NASDAQ:UPB) trade information
After registering a -5.34% downside in the last session, Upstream Bio Inc (UPB) has traded red over the past five days. The 5-day price performance for the stock is -20.71%, and -7.41% over 30 days. With these gigs, the year-to-date price performance is -53.65%. Short interest in Upstream Bio Inc (NASDAQ:UPB) saw shorts transact 3.7 million shares and set a 15.04 days time to cover.
The extremes give us $75 and $75 for target low and target high price respectively. As such, UPB has been trading -884.25% off suggested target high and -884.25% from its likely low.
Upstream Bio Inc (UPB) estimates and forecasts
The rating firms project that company’s revenue will shrink -36.64% compared to the previous financial year.
Revenue forecast for the current quarter as set by 4 analysts is 326.25k. Meanwhile, for the current quarter, a total of 4 analyst(s) estimate revenue growth to 352.75k.
UPB Dividends
Upstream Bio Inc has its next earnings report out on 2025-Mar-11. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Upstream Bio Inc (NASDAQ:UPB)’s Major holders
Upstream Bio Inc insiders hold 19.80% of total outstanding shares, with institutional holders owning 87.82% of the shares at 109.50% float percentage. In total, 87.82% institutions holds shares in the company.
We also have Fidelity Small Cap Growth Fund and Health Care Portfolio as the top two Mutual Funds with the largest holdings of the Upstream Bio Inc (UPB) shares. Going by data provided on Dec 31, 2024 , Fidelity Small Cap Growth Fund holds roughly 1.23 shares. This is just over 2.29% of the total shares, with a market valuation of $9.35 million. Data from the same date shows that the other fund manager holds a little less at 853.67, or 1.59% of the shares, all valued at about 6.5 million.
